Article

Assessment of ventricular mechanical dyssynchrony by short-axis MRI.

Eindhoven University of Technology, and Department of Radiology, Catharina Hospital, the Netherlands.
Conference proceedings: ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Conference 02/2007; 2007:6012-5. DOI:10.1109/IEMBS.2007.4353718 pp.6012-5
Source: PubMed

ABSTRACT Nowadays, patients with symptomatic heart failure and intraventricular conduction delay can be treated with a cardiac resynchronization therapy. Electrical dyssynchrony is typically adopted to represent myocardial dyssynchrony, to be compensated by cardiac resynchronization therapy. One third of the patients, however, does not respond to the therapy. Therefore, imaging modalities aimed at the mechanical dyssynchrony estimation have been recently proposed to improve patient selection criteria. This paper presents a novel fully-automated method for regional mechanical left-ventricular dyssynchrony quantification in short-axis magnetic resonance imaging. The endocardial movement is described by time-displacement curves with respect to an automatically-determined reference point. These curves are analyzed for the estimation of the regional contraction timings. Four methods are proposed and tested for the contraction timing estimation. They were evaluated in two groups of subjects with and without left bundle branch block. The standard deviation of the contraction timings showed a significant increase for left bundle branch block patients with all the methods. However, a novel method based on phase spectrum analysis shows a better specificity and sensitivity. This method may therefore provide a valuable prognostic indicator for heart failure patients with dyssynchronous ventricular contraction, adding new possibilities for regional timing analysis.

0 0
 · 
0 Bookmarks
 · 
88 Views
  • Article: QRS duration and mortality in patients with congestive heart failure.
    [show abstract] [hide abstract]
    ABSTRACT: It has been suggested that prolongation of the QRS duration (>120 ms) is an independent risk factor for mortality in patients with cardiomyopathy. The purpose of this study was to examine the association between QRS duration and survival in patients with heart failure. We performed a retrospective analysis to examine the association between QRS prolongation (> or =120 ms) and mortality. The study population included 669 patients with heart failure. Two groups, on the basis of baseline QRS duration <120 milliseconds or > or =120 milliseconds, were identified. The groups were compared with respect to total mortality and sudden death. Subgroups were also stratified by right bundle branch block and left bundle branch block, ejection fraction (EF) <30% and > or =30% to 40%, ischemic and nonischemic cardiomyopathy, amiodarone and placebo. Prolonged QRS was associated with a significant increase in mortality (49.3% vs 34.0%, P =.0001) and sudden death (24.8% vs 17.4%, P =.0004). Left bundle branch block was associated with worse survival (P =.006) but not sudden death. In patients with an EF <30%, QRS prolongation continued to be associated with a significant increase in mortality (51.6% vs 41.1%, P =.01) and sudden death (28.8% vs 21.1%, P =.02). In those with an EF of 30% to 40%, QRS prolongation was associated with a significant increase in mortality (42.7% vs 23.3%, P =.0036) but not in sudden death (13.3% vs 12.0%, P =.625). After adjustment for baseline variables, independent predictors of mortality were found to be prolongation of QRS (P =.0028, risk ratio 1.46) and depressed EF (P =.0001, risk ratio 0.965). Age, type of cardiomyopathy, and drug treatment group were not predictive of mortality. QRS prolongation is an independent predictor of both increased total mortality and sudden death in patients with heart failure.
    American heart journal 06/2002; 143(6):1085-91. · 4.65 Impact Factor
  • Article: Retiming the failing heart: principles and current clinical status of cardiac resynchronization.
    [show abstract] [hide abstract]
    ABSTRACT: Left or biventricular (BiV) pacing, or cardiac resynchronization therapy, was proposed nearly 10 years ago as an adjunctive treatment for patients with advanced heart failure (HF) complicated by discoordinate contraction due to intraventricular conduction delay. Since then, both short-term and a growing number of long-term clinical trials have reported on the mechanisms and short- and mid-term efficacy of this approach, with encouraging results. Therapy is implemented with novel pacing systems incorporating an endocardial lead to stimulate the lateral free wall via a cardiac vein, and often a right ventricular (RV) apex lead to provide BiV stimulation. A third atrial sensing lead monitors intrinsic rhythm and provides timing data to ensure ventricular pre-excitation. Modulation of the electronic atrial-ventricular (AV) time delay can optimize contractile synchrony, enhance the contribution of atrial systole, and reduce mitral regurgitation. Individuals with advanced HF, a wide QRS complex often with an AV time delay, and evidence of contraction dyssynchrony in viable myocardium represent the target patient group. Short-term studies reveal systolic augmentation and chamber efficiency from pacing resynchronization that can be substantial. Long-term studies reveal improved symptoms and exercise capacity, and some report reversal of chronic cardiac dilation. However, important questions regarding long-term efficacy and mortality impact, optimal mode for pacing stimulation, and role of combined pacing/cardioverter/defibrillation devices remain unresolved. Here we review pathophysiologic mechanisms, short- and long-term clinical results, and future directions of this new and promising therapy.
    Journal of the American College of Cardiology 02/2002; 39(2):194-201. · 14.16 Impact Factor
  • Article: Significance of QRS complex duration in patients with heart failure.
    [show abstract] [hide abstract]
    ABSTRACT: Prolongation of QRS (> or =120 ms) occurs in 14% to 47% of heart failure (HF) patients. Left bundle branch block is far more common than right bundle branch block. Left-sided intraventricular conduction delay is associated with more advanced myocardial disease, worse left ventricular (LV) function, poorer prognosis, and a higher all-cause mortality rate compared with narrow QRS complex. It also predisposes heart failure patients to an increased risk of ventricular tachyarrhythmias, but the incidence of cardiac or sudden death remains unclear because of limited observations. A progressive increase in QRS duration worsens the prognosis. No electrocardiographic measure is specific enough to provide subgroup risk categorization for excluding or selecting HF patients for prophylactic implantable cardioverter-defibrillator (ICD) therapy. In ICD patients with HF, a wide underlying QRS complex more than doubles the cardiac mortality compared with a narrow QRS complex. There is a high incidence of an elevated defibrillation threshold at the time of ICD implantation in patients with QRS > or =200 ms. Mechanical LV dyssynchrony potentially treatable by ventricular resynchronization occurs in about 70% of HF patients with left-sided intraventricular conduction delay, a fact that would explain the lack of therapeutic response in about 30% of patients subjected to ventricular resynchronization according to standard criteria relying on QRS duration. The duration of the basal QRS complex does not reliably predict the clinical response to ventricular resynchronization, and QRS narrowing after cardiac resynchronization therapy does not correlate with hemodynamic and clinical improvement. Mechanical LV dyssynchrony is best shown by evolving echocardiographic techniques (predominantly tissue Doppler imaging) currently in the process of standardization.
    Journal of the American College of Cardiology 12/2005; 46(12):2183-92. · 14.16 Impact Factor

Full-text

View
1 Download
Available from

Keywords

automatically-determined reference point
 
branch block patients
 
cardiac resynchronization therapy
 
contraction timing estimation
 
contraction timings
 
dyssynchronous ventricular contraction
 
Electrical dyssynchrony
 
heart failure patients
 
intraventricular conduction delay
 
mechanical dyssynchrony estimation
 
myocardial dyssynchrony
 
novel fully-automated method
 
patient selection criteria
 
phase spectrum analysis
 
regional contraction timings
 
regional mechanical left-ventricular dyssynchrony quantification
 
short-axis magnetic resonance imaging
 
standard deviation
 
symptomatic heart failure
 
valuable prognostic indicator